IL1B and hepatocellular carcinoma: TAMs also release a number of other inflammatory cytokines, such as IL-1β, IL-8, and TGF- β1, which have been shown to drive the EMT of HCC cells, contributing to more aggressive tumour phenotypes and metastasis [98].